Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endostar with Nedaplatin and 5-Fu in Refractory Nasopharyngeal Carcinoma
NCT02590133Phase 2Unknown
- Start
- Jul 2015
- Primary completion
- Dec 2018
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of endostar in nasopharyngeal carcinoma (NPC). Status: unknown.
02
Drugs
endostar
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT02590133.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02590133.